Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

AKUMS DRUGS & PHARMACEUTICALS LTD.

NSE : AKUMSBSE : 544222ISIN CODE : INE09XN01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE781.4531.35 (+4.18 %)
PREV CLOSE () 750.10
OPEN PRICE () 738.90
BID PRICE (QTY) 780.75 (13)
OFFER PRICE (QTY) 781.45 (33)
VOLUME 13630
TODAY'S LOW / HIGH ()738.90 784.00
52 WK LOW / HIGH ()410.1 796.2
NSE774.6525 (+3.33 %)
PREV CLOSE() 749.65
OPEN PRICE () 753.00
BID PRICE (QTY) 774.65 (99)
OFFER PRICE (QTY) 775.00 (259)
VOLUME 359186
TODAY'S LOW / HIGH() 740.50 784.40
52 WK LOW / HIGH ()409.3 796.55
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2004

Management Info :

- Chairman Sanjeev Jain - Managing Director

Registered Office :

Address : 304 Mohan Place,L S C, Block C,Saraswati Vihar,
New Delhi,
Delhi-110034

Phone : 011- 47511000

Website : www.akums.in

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
03Sep Akums Drugs and Pharmaceuticals inform
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
10Aug Akums Drugs reports 58% jump in Q1 con
Akums Drugs and Pharmaceuticals has reported results for first quarter e..
10Aug Akums Drugs climbs on reporting 58% ju
Akums Drugs & Pharmaceuticals is currently trading at Rs. 736.20, up..
10Aug Akums Drugs and Pharmaceuticals inform
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Re..
24Jul Akums Drugs’ arm gets nod to acquire O
Akums Drugs and Pharmaceuticals’ wholly-owned subsidiary -- Pure and Cur..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit448.391116.4
Gross Profit 593.36 1483.65
Operating Profit 746.072104.25
Net Sales 3922.7513487.36
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 25560.75 (1.14%)
M.Cap ( in Cr)
54249.47
Onesource Specialty (BSE)
 1601.30 (3.61%)
M.Cap ( in Cr)
18389.52
SMS Pharmaceuticals (BSE)
 462.10 (10.25%)
M.Cap ( in Cr)
4336.09
Torrent Pharma (BSE)
 4968.90 (0.82%)
M.Cap ( in Cr)
189012.40
Rubicon Research (BSE)
 1828.70 (2.13%)
M.Cap ( in Cr)
29605.38
Shareholding Pattern
PROMOTERS 75.26%
MUTUAL FUNDS/UTI 9.77%
NON-INSTITUTION 9.39%
FI/BANKS/INSURANCE 0.37%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74858.22-44.37 (-0.06%)
NIFTY23396.55-81.25 (-0.35%)
Dow Jones 52064.10-316.56 (-0.60%)
Nasdaq 26081.72-171.62 (-0.65%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI